AMD3100/CXCR4 inhibitor

被引：71

作者：

De Clercq, Erik ^{[1
]}

机构：

[1] Katholieke Univ Leuven, Rega Inst Med Res, Dept Microbiol & Immunol, Leuven, Belgium

来源：

FRONTIERS IN IMMUNOLOGY | 2015年 / 6卷

关键词：

anti-HIV; CXCR4; bicyclam; AMD3100; stem cell; HUMAN-IMMUNODEFICIENCY-VIRUS; BICYCLAM DERIVATIVE JM3100; CHEMOKINE RECEPTOR CXCR4; X4; HIV-1; REPLICATION; POTENT INHIBITORS; SELECTIVE-INHIBITION; PROGENITOR CELLS; ANTAGONISTS; MOBILIZATION; CORECEPTOR;

D O I：

10.3389/fimmu.2015.00276

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

071005 [微生物学]; 100108 [医学免疫学];

摘要：

引用

页数：3

共 23 条

[1]

Synthesis and Structure-Activity Relationships of Azamacrocyclic C-X-C Chemokine Receptor 4 Antagonists: Analogues Containing a Single Azamacrocyclic Ring are Potent Inhibitors of T-Cell Tropic (X4) HIV-1 Replication [J].

Bridger, Gary J. ;

Skerlj, Renato T. ;

Hernandez-Abad, Pedro E. ;

Bogucki, David E. ;

Wang, Zhongren ;

Zhou, Yuanxi ;

Nan, Susan ;

Boehringer, Eva M. ;

Wilson, Trevor ;

Crawford, Jason ;

Metz, Markus ;

Hatse, Sigrid ;

Princen, Katrien ;

De Clercq, Erik ;

Schols, Dominique .

JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (03) :1250-1260

[2]

Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist [J].

Broxmeyer, HE ;

Orschell, CM ;

Clapp, DW ;

Hangoc, G ;

Cooper, S ;

Plett, PA ;

Liles, WC ;

Li, XX ;

Graham-Evans, B ;

Campbell, TB ;

Calandra, G ;

Bridger, G ;

Dale, DC ;

Srour, EF .

JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (08) :1307-1318

[3]

HIGHLY POTENT AND SELECTIVE-INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS BY THE BICYCLAM DERIVATIVE JM3100 [J].

DE CLERCQ, E ;

YAMAMOTO, N ;

PAUWELS, R ;

BALZARINI, J ;

WITVROUW, M ;

DEVREESE, K ;

DEBYSER, Z ;

ROSENWIRTH, B ;

PEICHL, P ;

DATEMA, R ;

THORNTON, D ;

SKERLJ, R ;

GAUL, F ;

PADMANABHAN, S ;

BRIDGER, G ;

HENSON, G ;

ABRAMS, M .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (04) :668-674

[4]

POTENT AND SELECTIVE-INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV)-1 AND HIV-2 REPLICATION BY A CLASS OF BICYCLAMS INTERACTING WITH A VIRAL UNCOATING EVENT [J].

DECLERCO, E ;

YAMAMOTO, N ;

PAUWELS, R ;

BABA, M ;

SCHOLS, D ;

NAKASHIMA, H ;

BALZARINI, J ;

DEBYSER, Z ;

MURRER, BA ;

SCHWARTZ, D ;

THORNTON, D ;

BRIDGER, G ;

FRICKER, S ;

HENSON, G ;

ABRAMS, M ;

PICKER, D .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (12) :5286-5290

[5]

The bicyclams, a new class of potent human immunodeficiency virus inhibitors, block viral entry after binding [J].

DeVreese, K ;

Reymen, D ;

Griffin, P ;

Steinkasserer, A ;

Werner, G ;

Bridger, GJ ;

Este, J ;

James, W ;

Henson, GW ;

Desmyter, J ;

Anne, J ;

DeClercq, E .

ANTIVIRAL RESEARCH, 1996, 29 (2-3) :209-219

[6]

The molecular target of bicyclams, potent inhibitors of human immunodeficiency virus replication [J].

DeVreese, K ;

KoflerMongold, V ;

Leutgeb, C ;

Weber, V ;

Vermeire, K ;

Schacht, S ;

Anne, J ;

DeClercq, E ;

Datema, R ;

Werner, G .

JOURNAL OF VIROLOGY, 1996, 70 (02) :689-696

[7]

AMD310, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor [J].

Donzella, GA ;

Schols, D ;

Lin, SW ;

Esté, JA ;

Nagashima, KA ;

Maddon, PJ ;

Allaway, GP ;

Sakmar, TP ;

Henson, G ;

De Clercq, E ;

Moore, JP .

NATURE MEDICINE, 1998, 4 (01) :72-77

[8]

Antiviral activity of the bicyclam derivative JM3100 against drug-resistant strains of human immunodeficiency virus type 1 [J].

Este, JA ;

DeVreese, K ;

Witvrouw, M ;

Schmit, JC ;

Vandamme, AM ;

Anne, J ;

Desmyter, J ;

Henson, GW ;

Bridger, G ;

DeClercq, E .

ANTIVIRAL RESEARCH, 1996, 29 (2-3) :297-307

[9]

Molecular interactions of cyclam and bicyclam non-peptide antagonists with the CXCR4 chemokine receptor [J].

Gerlach, LO ;

Skerlj, RT ;

Bridger, GJ ;

Schwartz, TW .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (17) :14153-14160

[10]

Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4 [J].

Hatse, S ;

Princen, K ;

Bridger, G ;

De Clercq, E ;

Schols, D .

FEBS LETTERS, 2002, 527 (1-3) :255-262

← 1 2 3 →